Home
Resources
Product Analysis
Acknowledgements
About
Home
References
Trading exchanges
Trading exchanges
NYSE
Products 1 to 10 of 23
Modify Display Properties
Biotech components
Business models
Country of production
Country of distribution
Intended consumer
Date added
Date last modified
Known funding amount
Funding types
Industry
Market status
Organization
Organization type(s)
Product categories
Production process
Source
Trading symbol
Value chain stage
Sort: Title (A-Z)
Date added (oldest-newest)
Date added (newest-oldest)
Date modified (oldest-newest)
Date modified (newest-oldest)
Title (A-Z)
Title (Z-A)
Organization (A-Z)
Organization (Z-A)
Accellerase TRIO
by
DuPont
+
Genencor
Biotech components:
Enzyme
Business models:
B2B
Country of production:
USA
Country of distribution:
N/A
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/09/20 09:09 (6 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Fuel and Energy
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
DWDP
(NYSE)
Value chain stage:
Input
Arctic Apple
by
Okanagan Specialty Fruits
+
Intrexon
Biotech components:
Plant
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
+
Canada
Intended consumer:
Consumer
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/10/02 15:47 (6 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Food
Production process:
Open Release
Source:
NASEM Database
Trading symbol:
XON
(NYSE)
Value chain stage:
Finished Product
Bio-based 1,4 Butanediol
by
BioAmber, Inc.
Biotech components:
Plant
Business models:
B2B
Country of production:
USA
Country of distribution:
Canada
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/11/08 14:28 (6 years ago)
Known funding amount:
3,000,000 CAN
Funding types:
Debtor-in-possession financing
+
Shareholder Investment
Industry:
Industrial
Market status:
More information needed
+
No longer on the market
Organization type(s):
Public Company
Product categories:
Chemical
Production process:
Closed Production
Source:
NASEM Database
Trading symbol:
BIOA
(NYSE)
Value chain stage:
Input
Bio-based Disodium Succinate
by
BioAmber, Inc.
Biotech components:
Plant
Business models:
B2B
Country of production:
USA
Country of distribution:
Canada
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/11/08 14:28 (6 years ago)
Known funding amount:
3,000,000 CAN
Funding types:
Debtor-in-possession financing
+
Shareholder Investment
Industry:
Food & Agriculture
Market status:
More information needed
+
No longer on the market
Organization type(s):
Public Company
Product categories:
Additive
Production process:
Closed Production
Source:
NASEM Database
Trading symbol:
BIOA
(NYSE)
Value chain stage:
Input
BIO-SA Based Heat Transfer Fluids
by
BioAmber, Inc.
Biotech components:
Plant
Business models:
B2B
Country of production:
Canada
Country of distribution:
N/A
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/11/08 14:28 (6 years ago)
Known funding amount:
155,600,000 USD
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
More information needed
+
No longer on the market
Organization type(s):
Public Company
Product categories:
Chemical
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
BIOA
(NYSE)
Value chain stage:
Input
BIO-SA Based Personal Care Products
by
BioAmber, Inc.
Biotech components:
Plant
Business models:
B2C
Country of production:
Canada
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/11/08 14:29 (6 years ago)
Known funding amount:
155,600,000 USD
Funding types:
Shareholder Investment
Industry:
Health
Market status:
More information needed
+
No longer on the market
Organization type(s):
Public Company
Product categories:
Personal Care
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
BIOA
(NYSE)
Value chain stage:
Finished Product
BIO-SA Based Polyurethanes
by
BioAmber, Inc.
Biotech components:
Plant
Business models:
B2B
Country of production:
Canada
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/11/08 14:29 (6 years ago)
Known funding amount:
155,600,000 USD
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
More information needed
+
No longer on the market
Organization type(s):
Public Company
Product categories:
Chemical
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
BIOA
(NYSE)
Value chain stage:
Input
BIO-SA Based Resins & Coatings
by
BioAmber, Inc.
Biotech components:
Plant
Business models:
B2C
Country of production:
Canada
Country of distribution:
Benelux
+
France
+
Iberia
+
Germany
+
Poland
+
Switzerland
+
UK
+
Ireland
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/11/08 14:30 (6 years ago)
Known funding amount:
155,600,000 USD
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
More information needed
+
No longer on the market
Organization type(s):
Public Company
Product categories:
Chemical
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
BIOA
(NYSE)
Value chain stage:
Finished Product
BIO-SA Based Solvents
by
BioAmber, Inc.
Biotech components:
Plant
Business models:
B2C
Country of production:
Canada
Country of distribution:
N/A
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/11/09 16:31 (6 years ago)
Known funding amount:
155,600,000 USD
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
More information needed
+
No longer on the market
Organization type(s):
Public Company
Product categories:
Chemical
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
BIOA
(NYSE)
Value chain stage:
Finished Product
BIO-SA Brand Flavor Enhancers
by
BioAmber, Inc.
Biotech components:
Plant
Business models:
B2B
Country of production:
Canada
Country of distribution:
N/A
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/11/08 14:31 (6 years ago)
Known funding amount:
155,600,000 USD
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
Market status:
More information needed
+
No longer on the market
Organization type(s):
Public Company
Product categories:
Additive
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
BIOA
(NYSE)
Value chain stage:
Input
1
2
3
Login
or
register
to add and edit products
Future
Bioengineered
Products
Home
Resources
Product Analysis
Acknowledgements
About
